Arcutis Biotherapeutics Income Statement (2020-2025) | ARQT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -1.84M-2.00M0.72M2.96M2.78M5.19M30.00M13.53M49.57M30.86M44.76M71.36M65.85M81.50M99.22M
Cost of Revenue 0.27M0.48M0.78M0.78M1.18M2.25M3.26M3.46M5.50M6.91M8.83M7.49M8.69M
Gross Profit 0.46M2.48M2.00M4.41M28.82M11.28M46.31M27.39M39.25M64.45M57.02M74.01M90.53M
Operating items
Research & Development 21.63M30.77M40.60M52.56M40.62M38.20M69.73M33.88M35.34M25.22M26.24M23.77M23.14M19.30M19.50M14.48M17.54M19.45M19.60M
Selling, General & Administrative 14.45M11.31M16.47M18.73M22.01M27.62M35.47M37.02M42.92M45.96M47.59M48.67M54.79M58.17M58.82M57.61M64.00M69.17M62.40M
Other Operating Expenses 0.27M0.48M0.78M0.78M1.18M2.25M3.26M3.46M5.50M6.91M8.83M7.49M8.69M
Operating Expenses 36.09M42.08M57.08M71.29M62.63M65.83M105.47M71.39M79.05M71.95M75.01M74.69M81.19M80.94M83.82M78.99M90.38M96.11M90.69M
Operating Income -36.09M-42.08M-57.08M-71.29M-62.63M-65.83M-104.75M-68.42M-76.27M-66.76M-36.90M-61.17M-31.62M-50.08M-39.07M-7.63M-24.53M-14.61M8.53M
EBIT -36.09M-42.08M-57.08M-71.29M-62.63M-65.83M-104.75M-68.42M-76.27M-66.76M-36.90M-61.17M-31.62M-50.08M-39.07M-7.63M-24.53M-14.61M8.53M
Non-operating items
Other Non Operating Income 0.04M0.07M0.10M-0.04M0.14M0.42M1.94M3.32M3.21M3.12M2.72M2.67M4.04M5.23M4.18M2.72M2.73M2.10M2.04M
Non Operating Income 0.04M0.07M0.10M-0.04M-1.70M-1.58M1.94M3.32M3.21M3.12M2.72M2.67M4.04M5.23M4.18M2.72M2.73M2.10M2.04M
Net income details
EBT -36.09M-42.08M-57.08M-71.29M-64.47M-67.83M-107.71M-72.02M-80.10M-70.99M-41.74M-66.26M-35.06M-52.33M-41.54M-10.46M-24.78M-15.54M7.49M
Tax Provisions 3.02M0.03M0.32M0.32M0.28M0.34M0.08M
Profit After Tax -36.04M-42.01M-56.98M-71.33M-64.32M-67.41M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M
Income from Continuing Operations -36.09M-42.08M-57.08M-71.29M-64.47M-67.83M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M
Consolidated Net Income -36.09M-42.08M-57.08M-71.29M-64.47M-67.83M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M
Income towards Parent Company -36.09M-42.08M-57.08M-71.29M-64.47M-67.83M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M
Net Income towards Common Stockholders -36.09M-42.08M-57.08M-71.29M-64.47M-67.83M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M
Additional items
EPS (Basic) -0.76-0.84-1.14-1.43-1.27-1.31-1.89-1.14-1.31-1.16-0.73-0.59-0.32-0.42-0.33-0.08-0.20-0.130.06
EPS (Weighted Average and Diluted) -0.76-0.84-1.14-1.43-1.27-1.31-1.89-1.14-1.31-1.16-0.73-0.59-0.32-0.42-0.33-0.08-0.20-0.130.06
Shares Outstanding (Weighted Average) 38.09M38.15M38.19M50.08M50.08M50.24M50.24M50.30M50.38M51.42M51.56M60.93M61.42M61.42M61.65M94.38M96.81M115.76M116.89M118.64M118.64M119.20M119.91M
Shares Outstanding (Diluted Average) 37.59M37.75M35.67M47.28M50.00M50.10M49.41M50.51M51.42M57.09M55.03M61.17M61.43M61.73M69.31M111.05M123.48M124.30M120.96M126.04M127.00M132.88M
EBITDA -36.00M-42.09M-56.96M-71.56M-65.09M-67.64M-108.05M-71.51M-79.43M-70.87M-44.66M-66.10M-35.52M-52.49M-40.71M-11.33M-25.19M-15.78M7.38M
Interest Expenses 1.84M2.00M4.90M6.92M7.04M7.35M7.56M7.76M7.48M7.48M6.65M5.55M2.98M3.03M3.07M
Tax Rate 1.07%